Home » Topics » Regulatory » Patents

Patents
RSS

Arylsulfonamides as inhibitors of PLA2, cytokine release and neurodegeneration

Sep. 16, 1998

Anthraquinone telomerase inhibitors developed at CRC Technology

Sep. 16, 1998

Integrin antagonists discovered as part of Lilly/Cor Therapeutics collaboration

Sep. 16, 1998

Amgen describes preparation and use of KGF proteins

Sep. 15, 1998

MRI contrast agents in development at Nycomed Imaging

Sep. 15, 1998

Antigestagenic steroid esters patented by Schering AG

Sep. 15, 1998

Adrenergic agents for BPH described by Abbott in patent literature

Sep. 15, 1998

Orally active anticoagulants in early development at Gedeon Richter

Sep. 14, 1998

Inhibitors of ICE activity described by Vertex

Sep. 14, 1998

Preparation and use of peptide bradykinin B2 receptor agonists described by Fournier

Sep. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...